Skip to main content
Premium Trial:

Request an Annual Quote

Alpco Names BioCat Exclusive Distributor in Germany

NEW YORK (GenomeWeb News) – BioCat said today it has signed an exclusive deal to distribute Alpco Diagnostics' products in Germany.

Salem, NH-based Alpco develops metabolism assays, including insulin ELISA kits, as well as assays for factors involved in diabetes, obesity, and cardiovascular diseases. Financial and other terms of the deal were not disclosed.

In a statement, Michael Ehret, CEO of Heidelberg, Germany-based BioCat, said that Alpco's ELISA kits have allowed his firm to build a solid customer base, and today's deal "will bring this collaboration to a new level."